NewtekOne's Lending Volume Trajectory Set to Reveal Whether Seven-Day Loan Launch Translated to Profitability
NewtekOne Inc (NEWT) reports first-quarter 2026 earnings tomorrow, April 30th, after market close, with analysts expecting the business development company to deliver $0.42 per share—a significant acceleration from the prior year. The central question: can NEWT sustain the momentum from four consecutive quarters of earnings beats while navigating a challenging environment for small business lending?
Part 1: Earnings Preview
NewtekOne operates as a business development company specializing in providing financial and business services to small and medium-sized enterprises across the United States, with core offerings including SBA 7(a) loans, equipment financing, lines of credit, and commercial real estate financing. The company reports tomorrow, April 30th, after market close, with the consensus estimate calling for $0.42 per share on revenue expectations that remain undisclosed by analysts. Most recently, NEWT reported $0.65 per share for the fourth quarter of 2025, meeting analyst expectations.
Compared to the same quarter last year when NEWT earned $0.35 per share, the current estimate of $0.42 represents +20.00% year-over-year growth—a robust acceleration that reflects the company's expanding loan portfolio and improved net interest margins. Three key themes define this earnings story:
Small Business Lending Momentum: NEWT's core SBA 7(a) loan origination business has benefited from strong demand among small businesses seeking growth capital, with the company's diversified lending platform positioning it to capture market share in an underserved segment. Investors will watch for loan origination volumes and portfolio quality metrics.
Net Interest Margin Expansion: Rising interest rates have supported wider spreads on NEWT's floating-rate loan portfolio, driving profitability improvements. The sustainability of these margins amid potential rate stabilization will be critical to maintaining earnings growth.
Credit Quality and Provisioning: As economic uncertainty persists, investors are focused on delinquency trends and loan loss provisions. NEWT's ability to maintain disciplined underwriting while growing its portfolio will determine whether the earnings beat streak continues.
Analyst commentary ahead of the release reflects cautious optimism. Recent guidance from management indicated Q1 2026 EPS in the range of $0.37–$0.47, with the consensus estimate of $0.42 sitting comfortably in the middle of that band. Full-year 2026 guidance of $2.15–$2.55 suggests management expects continued momentum, though the wide range acknowledges macroeconomic uncertainties. Analysts at Piper Sandler recently raised their price target to $14, citing improving loan origination trends and stable credit metrics, while maintaining a neutral rating pending further evidence of sustained profitability.
Part 2: Historical Earnings Performance
NewtekOne has established a consistent pattern of exceeding analyst expectations, delivering earnings beats in three of the last four quarters. The company reported $0.35 in Q1 2025 (beating by +2.94%), $0.52 in Q2 2025 (beating by +4.00%), $0.67 in Q3 2025 (beating by +6.35%), and $0.65 in Q4 2025 (matching estimates). This track record demonstrates management's ability to execute on guidance and suggests conservative analyst modeling.
The magnitude of beats has been modest but steady, ranging from in-line to +6.35% above consensus. Notably, the Q3 2025 surprise of +6.35% represented the strongest outperformance in the recent period, driven by better-than-expected net interest income and lower credit provisions. The Q4 2025 result, while meeting estimates exactly, still reflected solid execution as the company navigated seasonal lending patterns.
The trend suggests NEWT has built credibility with the Street through disciplined guidance and consistent delivery. With the Q1 2026 estimate of $0.42 representing +20.00% year-over-year growth, investors will be watching whether the company can maintain its beat streak while managing higher growth expectations.
| Quarter | EPS Estimate | EPS Actual | Surprise % | Beat/Miss |
|---|---|---|---|---|
| Mar 2025 | $0.34 | $0.35 | +2.94% | Beat |
| Jun 2025 | $0.50 | $0.52 | +4.00% | Beat |
| Sep 2025 | $0.63 | $0.67 | +6.35% | Beat |
| Dec 2025 | $0.65 | $0.65 | unch | Beat |
Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
NewtekOne reports after market close, meaning Day 0 captures anticipatory trading before results are released, while Day +1 reflects the market's first full reaction to the actual earnings.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-01-29 | +$0.64 (+4.68%) | $0.57 (4.17%) | -$0.82 (-5.73%) | $1.41 (9.85%) |
| 2025-10-29 | -$0.28 (-2.59%) | $0.52 (4.76%) | -$0.34 (-3.22%) | $1.28 (12.13%) |
| 2025-07-28 | +$0.11 (+0.94%) | $0.45 (3.84%) | -$0.43 (-3.64%) | $0.74 (6.26%) |
| 2025-05-06 | -$0.30 (-3.05%) | $0.37 (3.76%) | +$0.37 (+3.88%) | $0.48 (5.03%) |
| 2025-02-26 | +$0.03 (+0.25%) | $0.42 (3.44%) | +$0.79 (+6.46%) | $1.19 (9.74%) |
| 2024-11-06 | +$1.40 (+10.61%) | $0.97 (7.35%) | -$0.37 (-2.53%) | $1.29 (8.80%) |
| 2024-08-05 | -$0.56 (-4.29%) | $0.45 (3.45%) | +$0.10 (+0.80%) | $0.83 (6.64%) |
| 2024-05-06 | -$0.08 (-0.72%) | $0.19 (1.70%) | +$1.25 (+11.28%) | $1.11 (10.00%) |
| Avg Abs Move | 3.39% | 4.06% | 4.69% | 8.56% |
NEWT's post-earnings price behavior shows moderate volatility with mixed directional bias. On Day 0 (anticipation), the stock has averaged an absolute move of 3.39% with an intraday range of 4.06%, reflecting pre-announcement positioning. Day +1 (first reaction session) shows larger moves, averaging 4.69% with a wider 8.56% intraday range, indicating that the market's true response emerges after digesting the full earnings release.
Recent history reveals significant variability: the November 2024 report triggered a +10.61% Day 0 surge followed by a -2.53% Day +1 pullback, while the January 2026 report saw a +4.68% Day 0 gain reverse to a -5.73% Day +1 decline despite meeting estimates. The February 2025 report showed muted Day 0 action (+0.25%) but a strong +6.46% Day +1 follow-through. This pattern suggests NEWT's earnings reactions are driven more by forward guidance and credit quality commentary than the headline EPS number itself, with investors taking time to assess the full implications.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 05/15/26 (DTE 16) |
| Expected Move | $1.08 (8.53%) |
| Expected Range | $11.58 to $13.74 |
| Implied Volatility | 96.84% |
The options market is pricing an 8.53% expected move for the May 15th expiration (16 days out), which is notably higher than NEWT's average historical Day +1 move of 4.69% but below the average intraday range of 8.56%. This suggests options traders are anticipating above-average volatility around this earnings release, possibly reflecting uncertainty around credit quality trends or the sustainability of margin expansion.
Part 3: What Analysts Are Saying
Analysts maintain a cautiously optimistic stance on NewtekOne, with the consensus rating at 3.50 (Hold) and an average price target of $16.60—representing +31.1% upside from the current price of $12.66. The rating breakdown shows 2 Strong Buys, 0 Moderate Buys, 6 Holds, 0 Moderate Sells, and 0 Strong Sells among 8 analysts covering the stock, reflecting a divided Street with most analysts taking a wait-and-see approach.
Sentiment has remained unchanged over the past month, with the rating distribution and average recommendation holding steady at 3.50. This stability suggests analysts are comfortable with their current positioning ahead of earnings, neither upgrading in anticipation of a beat nor downgrading due to emerging concerns. The price target range spans $12.00 to $25.00, with the wide spread reflecting differing views on NEWT's valuation multiple and growth sustainability.
The $16.60 mean target implies analysts see meaningful upside potential if the company can deliver on its full-year guidance range of $2.15–$2.55 and maintain credit quality. However, the predominance of Hold ratings suggests most analysts want to see another quarter or two of execution before upgrading to more bullish stances. Recent target increases from firms like Piper Sandler (to $14) reflect improving fundamentals but maintain neutral ratings, indicating the Street is acknowledging progress while remaining selective about entry points.
Part 4: Technical Picture
NewtekOne enters earnings with strengthening technical momentum, as the Barchart Technical Opinion has improved from a 40% Sell signal one month ago to a 56% Buy signal last week and now stands at a 72% Buy—a significant positive shift that suggests growing bullish conviction heading into the release.
Timeframe Analysis:
- Short-term (50% Buy): Moderate buy signal indicates near-term momentum is positive but not overwhelming, reflecting some consolidation after recent gains
- Medium-term (50% Buy): Matching the short-term reading suggests consistent momentum across intermediate timeframes without clear directional dominance
- Long-term (100% Buy): Strong buy signal reflects robust strength in the longer-term trend, indicating the stock has established a solid uptrend over multiple months
Trend Characteristics: The trend is characterized as Soft and Weakening, suggesting that while the directional bias remains positive, momentum may be losing steam heading into earnings—a setup that could amplify volatility if results disappoint or provide fuel for a breakout if the company beats and raises guidance.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $12.80 | 50-Day MA | $12.11 |
| 10-Day MA | $12.84 | 100-Day MA | $12.43 |
| 20-Day MA | $12.37 | 200-Day MA | $11.86 |
The stock is trading at $12.66, positioned above its 20-day ($12.37), 50-day ($12.11), and 200-day ($11.86) moving averages, confirming the longer-term uptrend. However, the price sits below both the 5-day ($12.80) and 10-day ($12.84) moving averages, indicating recent short-term weakness or consolidation. This technical setup is moderately supportive for earnings: the stock has room to run if results exceed expectations and guidance is raised, but the recent pullback from short-term moving averages suggests some profit-taking ahead of the event. Key resistance lies at the $12.80–$12.84 zone (5-day and 10-day MAs), while support sits at the 20-day MA of $12.37. A beat-and-raise scenario could propel NEWT toward the $13.74 upper end of the options-implied range, while a miss could test the 50-day MA at $12.11.